BMC Cardiovascular Disorders

Table 1 Cardiovascular risk factors at baseline and follow-up in patients without the metabolic syndrome1 and diabetes mellitus²

From: Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care

		Baseline			8 weeks			difference²
		N	mean	± SD	N	mean	± SD	N	mean	± SD
Blood pressure
systolic	mmHg	354	159.8	14.7	348	133.0	10.8	341	-27.0*	14.5
diastolic	mmHg	353	93.3	9.3	348	80.7	6.0	340	-12.8*	10.1
Fasting plasma glucose
	mg/dL	354	85.9	11.5	205	86.8	14.5	203	1.7	15.0
Waist circumference
men	cm	141	97.9	10.4	135	96.8	9.7	133	-0.8*	1.9
women	cm	142	88.8	11.7	130	87.8	10.5	130	-0.6*	2.8
Triglycerides
	mg/dL	351	138.0	80.6	197	137.7	57.6	195	0.3	3.86
HDL Cholesterol
men	mg/dL	169	54.1	13.9	94	53.8	13.2	94	1.6	10.7
women	mg/dL	183	67.4	17.3	96	66.6	17.1	95	-0.7	15.8

¹ defined by the AHA/NHLBI 2004 [17]; ² diagnosis assigned by physician; ³ difference versus baseline; statistical test applied: t-test; * p < 0.0001. Adjusted for age.

Back to article page

ISSN: 1471-2261

Contact us

Submission enquiries: bmccardiovasculardisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com